Compare LPX & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LPX | TFX |
|---|---|---|
| Founded | 1973 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Forest Products | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.3B |
| IPO Year | 1994 | 1994 |
| Metric | LPX | TFX |
|---|---|---|
| Price | $73.98 | $128.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | $105.29 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 1.1M | 697.7K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.67% | 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $2,708,000,000.00 | $1,992,713,000.00 |
| Revenue This Year | N/A | $15.97 |
| Revenue Next Year | $11.23 | $5.15 |
| P/E Ratio | $189.21 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $66.12 | $100.18 |
| 52 Week High | $102.86 | $139.67 |
| Indicator | LPX | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 51.68 | 48.87 |
| Support Level | $68.13 | $117.57 |
| Resistance Level | $76.81 | $130.56 |
| Average True Range (ATR) | 2.96 | 3.45 |
| MACD | 0.45 | -0.88 |
| Stochastic Oscillator | 70.98 | 31.44 |
Louisiana-Pacific Corp is an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The Siding business of the company serves different markets with a broad product portfolio of engineered wood siding, trim, soffit, and fascia. The Company operates through three operating segments: Siding, OSB, and LP South America (LPSA). The company generates majority of its revenue from siding segment.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.